Keryx Price Target Lifted
Posted on January 29, 2013 at 10:54 AM EST
Stifel Nicolaus lifted its price target on Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) from $4 to $13 per share sending the stock price soaring $2.02 to $8.08.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here